These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 6302168

  • 1. [Relapses of malignant nonseminomatous germinal testicular tumors].
    Piot G, Droz JP, Caillaud JM, Bellet D, Wibault P, Brulé G, Amiel JL.
    J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
    [Abstract] [Full Text] [Related]

  • 2. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 3. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA.
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [Abstract] [Full Text] [Related]

  • 4. Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
    de Wit R.
    J Clin Oncol; 2007 Dec 10; 25(35):5550-2. PubMed ID: 18065727
    [No Abstract] [Full Text] [Related]

  • 5. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
    Wobbes T, Schraffordt Koops H, Oldhoff J, Sleijfer DT, Oosterhuis JW.
    Neth J Surg; 1983 Jul 10; 35(3):89-93. PubMed ID: 6310445
    [No Abstract] [Full Text] [Related]

  • 6. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF, Winkler M, Savage P, Seckl MJ, Christmas TJ.
    BJU Int; 2007 Oct 10; 100(4):809-12. PubMed ID: 17711512
    [Abstract] [Full Text] [Related]

  • 7. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
    von Eschenbach AC, Swanson DA, Johnson DE, Wishnow KI, Stephenson RA, Babaian RJ.
    Prog Clin Biol Res; 1991 Oct 10; 370():385-92. PubMed ID: 1718009
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N.
    Prog Clin Biol Res; 1985 Oct 10; 203():271-86. PubMed ID: 2421330
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA, Bokemeyer C, Serth J, Machtens S, Höfner K, Jonas U.
    Urologe A; 1996 Jan 10; 35(1):35-45. PubMed ID: 8851847
    [Abstract] [Full Text] [Related]

  • 10. Management of patients with non-seminomatous germ cell tumours stage I.
    Rørth M, Cullen MH, Horwich A, Roth BJ.
    Prog Clin Biol Res; 1990 Jan 10; 357():295-303. PubMed ID: 2170995
    [No Abstract] [Full Text] [Related]

  • 11. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D, Farmakis D, Pectasides M.
    Oncology; 2006 Jan 10; 71(3-4):151-8. PubMed ID: 17646698
    [Abstract] [Full Text] [Related]

  • 12. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A, Carver BS, Stasi J, Bajorin DF, Motzer RJ, Bosl GJ, Sheinfeld J.
    Cancer; 2008 Feb 15; 112(4):800-5. PubMed ID: 18172902
    [Abstract] [Full Text] [Related]

  • 13. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
    Drianno N, Robert M, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1997 Sep 15; 7(4):622-7. PubMed ID: 9410322
    [Abstract] [Full Text] [Related]

  • 14. [Role of the excision of thoracic lesions in the treatment of metastatic malignant germinal tumors of the testis].
    Richer O, Droz JP, Lemoine G, Levasseur P, Amiel JL, Brulé G.
    J Urol (Paris); 1982 Sep 15; 88(6):349-51. PubMed ID: 6184419
    [Abstract] [Full Text] [Related]

  • 15. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T, Goepel M, Seeber S, Rübben H.
    Urologe A; 1993 May 15; 32(3):189-93. PubMed ID: 7685554
    [Abstract] [Full Text] [Related]

  • 16. [Follow-up of patients with localized germinal testicular tumors: 6 years' experience at the "Santa Creu i Sant Pau" Hospital].
    Climent Duran MA, Germa Lluch JR, Seguí Palmer MA, Fernández Sagarra A, Izquierdo Delso MA, Lacasta Muñoa A.
    Arch Esp Urol; 1992 May 15; 45(1):21-4. PubMed ID: 1316741
    [Abstract] [Full Text] [Related]

  • 17. Wait-and-see policy in clinical stage I non-seminomatous germ cell tumors of the testis.
    Schraffordt Koops H, Sleijfer DT, Oosterhuis JW, Marrink J, de Bruijn HW, Oldhoff J.
    Eur J Surg Oncol; 1986 Sep 15; 12(3):283-7. PubMed ID: 3019779
    [Abstract] [Full Text] [Related]

  • 18. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P, Haas RJ, Göbel U, Calaminus G.
    Klin Padiatr; 2002 Sep 15; 214(4):167-72. PubMed ID: 12165897
    [Abstract] [Full Text] [Related]

  • 19. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5597-602. PubMed ID: 18065732
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.